Related Experiment Video
Updated: Sep 19, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Heart Failure With Improved Ejection Fraction: Definitions, Epidemiology, and Management
Mauro Riccardi1, Maria A Pabon2, Ankeet S Bhatt3
1Division of Cardiology, Cremona Hospital, Cremona, Italy; Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Heart failure with improved ejection fraction (HFimpEF) is a distinct condition where ejection fraction recovers. Further research is needed to understand HFimpEF prognosis and optimize treatment strategies for these patients.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Heart failure with improved ejection fraction (HFimpEF) is defined by a recovery of left ventricular ejection fraction (LVEF) from ≤40% to >40%.
- HFimpEF is increasingly recognized but remains understudied, with ongoing uncertainty regarding its long-term outcomes and best management practices.
- Rising prevalence may be linked to better guideline-directed medical therapy and refined diagnostic criteria.
Purpose of the Study:
- To provide a comprehensive review of HFimpEF, covering its epidemiology, pathophysiology, prognosis, and therapeutic interventions.
- To identify current clinical knowledge gaps in HFimpEF management.
- To suggest future research directions for improved risk stratification and treatment.
Main Methods:
- Literature review of contemporary registries and clinical trials.
- Analysis of epidemiological data and prognostic factors.
- Evaluation of current treatment strategies and guidelines.
Main Results:
- HFimpEF represents a significant and growing patient population within the heart failure spectrum.
- Despite LVEF improvement, patients with HFimpEF face continued risks for adverse cardiovascular events.
- Optimal management strategies for HFimpEF are still under active investigation and require further research.
Conclusions:
- HFimpEF is a distinct clinical entity requiring tailored research and management approaches.
- Further investigation is crucial to refine risk assessment and therapeutic strategies for patients with HFimpEF.
- Addressing clinical gaps will enhance the care and outcomes for individuals experiencing improved ejection fraction in heart failure.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Heart Failure II: Pathophysiology
Heart Failure I: Introduction

